CIGB-128

3 trials

Sponsors

Center for Genetic Engineering and Biotechnology (CIGB)

Conditions

KeloidsSkin basal cell carcinoma (BCC)

Phase 2

CIGB-128 administration to patients with surgically-treated keloids.

RecruitingRPCEC00000062

Center for Genetic Engineering and Biotechnology (CIGB)Keloids

Start: 2003-11-13Target: 30Updated: 2026-03-30

Application of CIGB-128 in keloid patients undergoing surgical exeresis.

Active, not recruitingRPCEC00000061

Center for Genetic Engineering and Biotechnology (CIGB)Keloids

Start: 2004-04-02Target: 45Updated: 2026-03-30

Active, not recruitingRPCEC00000066

Center for Genetic Engineering and Biotechnology (CIGB)Skin basal cell carcinoma (BCC)

Start: 2001-03-26Target: 60Updated: 2026-03-30